Karolis has more than 15 years’ experience across healthcare, technology and finance businesses.

Prior to his appointment, he was CEO and Co-Founder for a nutrition technology business, OME Health. He also co-founded SingCell, a stem cell contract development and manufacturing organisation.

Mr Rosickas had previously held senior positions with investment banking company HSBC, JP Morgan, KPMG and multinational food-products corporation, Danone.

He is a certified chartered financial analyst and with a Masters in Business Administration.

Regeneus Independent Chairman Barry Sechos said Karolis’ appointment would be a significant step for the company’s growth.

“His experience in the healthcare and finance sectors will be invaluable for the company, furthermore, his experience as a Co-Founder of an organisation dedicated to stem cell development and manufacturing will be critical for Regeneus’ next phase of growth,” he said.

“We thank Leo for his service and are delighted that the company will continue to benefit from his strategic guidance as a Non-Executive Director,” he added.

Meanwhile, Leo Lee has resigned as CEO of the company for a new role in a major Japanese pharmaceutical company. He’ll remain on the Regeneus board as a Non-Executive Director.  

Shares in Regeneus closed 7.41 per cent lower, at 12.5 cents. 

The company’s US asset portfolio consists of Gold, Gold/Copper and Lithium projects, that are all at various stages of exploration.

Under the strongly supported placement to institutional and professional investors, shares will be issued at 0.012 cents. Participants will also receive 2 free attaching unquoted options, per 3 new shares. The unquoted options will be exercisable at 0.2 cents and expire in 2 years, however, this is subject to shareholder approval.

With a boost in the Company’s balance sheet, Hawkstone plans to use the funds for continued exploration, drilling and metallurgical studies across its projects in the U.S.

In more detail, part of the funds will be used to continue exploration at the Long Pine Gold project in Idaho, with enough funds for follow up drilling in 2021.

Drilling at the Western Desert and Devils Canyon project is also set to commence around April or March next year.

As for its Big Sandy Lithium project in Arizona, the company is planning to progress the project, which includes metallurgical studies.

To add to the news results from the remaining five holes at the Lone Pine Gold project are expected to be available in two weeks.

Hawkstone Managing Director Paul Lloyd said the company is pleased with the strong support in the placement.

“We are now funded to continue targeting and refinement at all three gold projects leading into follow up drilling in the first half of 2021,” Paul said.

“With assay results pending from Lone Pine and gold exploration projects in well-endowed gold producing regions, it is an exciting time for all Hawkstone stakeholders,” he added.

Shares in Hawkstone Mining have been 7.14 per cent lower, at 1.3 cents.

The SPP followed the recent oversubscribed $45 million institutional placement, with 30 million shares issued to institutional, sophisticated and professional investors at $1.50. 

Under the SPP, 2.6 million shares will be issued at the same price as the institutional placement.

The combined total of $48.9 million will be used to accelerate the commercialisation of its COVID-19 SPL7013 nasal spray, fast-track and advance its dendrimer drug delivery candidates as well as strengthening the company’s balance sheet.

Starpharma’s SPL7013 nasal spray works by blocking the interaction between viral surface proteins and human cell receptor proteins, which has demonstrated significant activity against the virus that causes COVID-19.

The company has three internal Dendrimer Enhanced Products (DEP), DEP docetaxel, DEP cabazitaxel and DEP irinotecan –  which are in clinical development for patients with solid tumours. 

Starpharma CEO Dr Jackie Fairley said the company is pleased with the support and the extra funds would advance activities across its products.

“This financing has further strengthened Starpharma’s balance sheet and places the company in an excellent position to accelerate the development, regulatory, commercialisation and launch activities across our portfolios, including the SPL7013 COVID-19 nasal spray and DEP assets,” she said.

Shares in Starpharma have been slightly lower on the market by 1.03 per cent, trading at $1.44.

Under the placement, 44 million shares will be issued at 7.5 cents, representing an 80.2 per cent discount to the 15-day volume-weighted average price.

Participants will also receive one attaching option for every four shares held, exercisable at 20 cents each.

The extra cash will be used for exploration works, with a focus on the recent high grade discovery at Gigante Grande. Funds will also be used to continue the development of the Mount Mackenzie gold asset.

Managing Director Richard Poole said the supported placement was off the back of recent results from the project.

“The strong support for the placement reflects the enormous excitement that the recent Gigante Grande results have generated and the growing interest and certainty that there are significant gold resources in the East Menzies Gold Field tenements,” he said.

The company is exploring the east of the tenement, whilst on the western side, scoping and pit optimisation studies have begun.

Settlement and allotment of the shares is due on November 2.

Shares in Resources & Energy closed 19.3 per cent higher on the market, at 10.5 cents.

The company originally planned to raise $2 million, however, applications exceeded the target and State Gas accepted all eligible participants.

The 246 valid applications received represented a participation rate of over a third of eligible shareholders, investing an average amount of about $20,000.

The SPP followed a recent $9.5 million raise completed by a private placement. The combined total will fund a bigger appraisal program at the company’s Reid’s Dome Gas project, as well as drilling and testing at the neighbouring Rolleston West project. The extra cash will also support planning and approval for a gas pipeline and infrastructure to export gas from both projects.

State Gas Executive Chairman Richard Cottee said the extra funds would position the company well.

“The proceeds from the SPP, when combined with the preceding private placement of $9.5 million, not only strengthens our resolve to meet our target 2022 objectives but also enable the company to take its first steps to creating a new ‘super-gas region’ within our wholly-owned acreage at a time of national need,” he said.

State Gas shares closed 4.2 per cent lower on the market, at 57 cents

The company provides a ‘market fresh and easy cooking’ meal kit service and has a market capitalisation of $660.3 million.

Money raised from the underwritten placement will be used for the company’s global growth strategy and balance sheet flexibility. The company will also use the cash to fund investments into infrastructure to service growth.

The oversubscribed placement had support from domestic and international institutional investors, including both existing security holders and new investors.

Over 17 million chess depository interests (CDI’s) will be issued at $3.22 each, which is a 5 per cent discount to MMM’s one-day volume weighted average price on October 22. The new CDI’s will rank equally with the company’s existing CDIs on issue.

The extra cash follows a strong third-quarter performance, in which the company announced it saw a 163 per cent growth in U.S.-based revenue.

The placement is expected to settle on October 29, with the new CDI’s tradable the following day.

Shares in Marley Spoon closed 31.2 per cent lower for $2.40.

Swisse Wellness is an Australian vitamin and skincare brand now selling the CBD products on its eCommerce channels and in-store at health-food chain Holland and Barrett.

The soft gel cap products are designed to target needs such as immune function and joint mobility.

The launch follows Bod’s exclusive partnership with Health and Happiness group (H&H), under which sits Swisse Wellness.

Bod and H&H already sell products in Australia, the U.K. and the Netherlands but plans to target other areas of Europe and the U.S.

Bod will receive a royalty on net product sales as well as a cost plus margin for the supply of its CBD products. Bod expects revenue from sales in the Netherlands to be realised this quarter.

Bod Australia CEO Jo Patterson said the company’s partnership with H&H was expected to grow in the months ahead.

“We have now collaboratively launched Swisse products into three major markets in a very short space of time and the Company is confident that our high-quality CBD products will be well received by consumers to address a range of mainstream need states,” she said.

“Bod will continue to work with H&H and Swisse on expanding the range beyond the first four CBD products and we expect the number of countries where we sell product to expand in the coming months.

“We are also working on product development initiatives for our proposed US market entry.”

Shares in the Bod Australia are trading 6.73 per cent higher at 55.5 cents just before market close.

Perpetual, which is developing the Beharra Sands Project near Geraldton in Western Australia, will use funds from the placement will be used to advance its pre-feasibility study at the site and fast-track its planned definitive feasibility study.

Ultimately, further work at Beharra will help the company capitalise on the strong demand for silica sands in the Asia Pacific and take advantage of rising prices.

Under the placement, about 50 million shares will be issued at four cents. 

Company directors have subscribed for a combined $150,000, however, this is subject to shareholder approval at the company’s upcoming annual general meeting (AGM).

Perpetual Resources Chairman, Julian Babarczy, said the company remained focussed on advancing the Beharra project.

“This additional capital will allow Perpetual to fast track a number of project-related studies at Beharra and will see us rapidly advance to a decision to fund,” he said. 

“We remain highly focussed on delivering the Beharra project in a manner that is highly accretive to shareholder value and this raising provides the financial support for this to occur,” Julian concluded.

Shares in Perpetual Resources closed 14.3 per cent higher, worth 4.8 cents.

The money will allow the company to fulfil its four existing PPE authentication contracts and establish new distribution networks for its products. Funds will also be used for sales and marketing activities and proof of concept costs for new business including the commercialisation of Dotz’s surface sanitation and onsite virus detection.

The strongly supported placement will issue over 28 million shares at a price of 25 cents, representing a 3.8 per cent discount to the 30-day volume weighted average price.

The company’s biggest shareholder, Southern Israel Bridge Fund, has committed $750,000 and directors will chip in $150,000 — subject to shareholder approval at a yet-to-be-announced extraordinary general meeting.

Dotz Chairman and interim CEO Bernie Brookes said the boost in funds will help push the company forward.

“We are now well-funded to increase production capacity to meet our obligations under existing long-term contracts, as well as accelerate our next growth phase within the broader anti-counterfeiting and authentication sectors,” he said.

“Our recent sales success in PPE authentication verifies the value of our end-to-end authentication technology in protecting the reputation of high-quality products throughout global supply chains,” the interim CEO continued.

Shares in Dotz Nano closed 3.45 per cent lower, priced at 28 cents.

Previously, the company completed a high-resolution aeromagnetic survey, which showed clear structures extending south into the Arden project from Taruga Minerals’ tenement to the north and down to the Mt Arden copper mine.

Taruga defined high-grade copper trends across its tenement in soil and surface rock chip samples over a prospective 15-kilometre length.

The Auroch program will sample the area of prospective strike modelled from the aeromagnetic data, stretching from Taruga’s tenement down to the historical artisanal Mt Arden prospect. 

The best rock-chip sampling results from the company’s previous program at Mt Arden were between five and 20 per cent copper.

The initial sampling program has begun at the Lady Margo prospect, north of Mt Arden and will take around three weeks. 

Once the initial program is complete, Auroch will move to cover other areas including the Kanyaka prospect, where surface rock chip samples produced results up to 12.4 per cent copper in 2018.

Auroch Managing Director Aidan Platel said encouraging prior results show the program has great potential.

“We have reviewed our high-resolution aeromagnetic data and can see those same structures extending south into our tenement and down to the Mt Arden region, where we know from our earlier sampling programmes there is high-grade copper outcropping at surface,” Aidan said.

“There is great potential for this sampling programme to define a significant strike length of high-grade copper at surface at Arden, and we have already identified further potential copper-rich areas within our tenure, that will be covered with surface-sampling programmes following this initial programme,” he said. 

Shares in Auroch Minerals closed 28.6 per cent higher for 13.5 cents.

Under the three-year contract, PayGroup will supply its Software-with-a-service (SwaS) payroll offering to Volvo, along with multiple Software-as-a-Service (SaaS) Human Capital Management (HCM) modules including; Core HR, E Leave, E Claims and E time.

The company acquired TalentOz in July 2020 and integrated its HCM technology with its SwaS payroll offering. This provided PayGroup with a full service HCM product suite that covers the entire “hire to retire” lifecycle.

The company now has 229 employees in 11 countries, servicing over 995 client entities, which represents more than five million payslips per annum.

PayGroup Managing Director Mark Samlal said the contract highlights the company’s portfolio growth.

“PayGroup and TalentOz technologies can now be offered to clients as a seamless solution, with an integrated customer interface,” Mark said.

“We expect this to be a very attractive customer proposition and look forward to continuing to capitalise on new market opportunities within Asia and Australia,” he said.

“Our sales of new contracts in H1 FY20 were $5.4 million, 98 per cent of the total new contract wins in FY20. We expect this strong sales momentum to continue into H2 FY20 and we are highly confident of the growth we can deliver,” he added.

Shares in the company have been 1.83 per cent higher, trading for 55.5 cents.

Under the contract, signed with Sundrop farms, De.mem will design, manufacture and commission a membrane-based water treatment plant.

Sundrop prides itself on sustainable agriculture — growing fresh fruits and vegetables using renewable inputs — in Port Augusta in South Australia.

The solution provided by De.mem combines different treatment steps, including ultrafiltration and reverse osmosis membranes into an automated system, which will be manufactured at the company’s Brisbane site.

The Australian-Singaporean water and wastewater treatment company’s plants produce high-quality water above the Australian drinking water standards.

De.mem CEO Andreas Kroell said it was a key opportunity for the company.

“With this project, De.mem further establishes itself as a supplier of decentralized seawater desalination systems for customers which have strict quality requirements,” he said.

“This is a substantial business opportunity for our company given that seawater desalination is considered one of the key growth segments within the water treatment industry,” Andreas continued.

“Furthermore, we are very pleased to see our company strengthen its position as a supplier into Australia’s food and beverage and agricultural sectors, which has been one of our key objectives for the ongoing calendar year,” he concluded.

While the project is underway, most of the revenue will reach the company next year.

Shares in De.mem closed grey for 24 cents.

Funds from the placement will be used for scoping and pre-feasibility studies, as well as lab testing to support the development of a high-grade lithium concentrate or lithium carbonate.

Under the placement around 23 million shares will be issued at 13 cents, representing a 12.8 per cent discount to the five-day volume weighted average price.

The placement was strongly supported by domestic and international investors, which resulted in bids over the original placement goal by 50 per cent.

Galan Lithium’s managing director Juan Pablo Vargas de le Vega said he was pleased with the support received for the placement.

“This placement enables us to further strengthen our share register and our balance sheet, which will enable Galan to continue to execute its Hombre Muerto West development strategy with vigour and unencumbered,” he said.

“We are delighted with the strong support received from existing shareholders and several new sophisticated institutional investors.”

Shares in the company have been trading 1.66 per cent lower, for 14.7 cents.

In September, the company entered a binding term sheet agreement to acquire Oz Gold with a 60-day period to exercise the option. As a result of quicker than expected progress, the company has elected to exercise the option, acquiring the Oz Gold’s Yarbu and Mt Dimer projects in WA.

Funds from the two-tranche placement will be primarily used for exploration at the Mt Dimer project, as well as exploration at the Rover project in WA.

Tranche one will involve the issue of over 121 million shares to raise $729,481.28

In tranche two, more than 311 million shares will be issued to raise over $1.8 million, upon receiving shareholder’s approval at the company’s annual general meeting in late November.

Shares will be issued at 0.6 cents, representing a 24 per cent discount to the 15-day volume-weighted average price.

In addition to the news, reverse circulation drilling is currently underway at the Rover project with a focus on four main target areas.

Shares in Twenty Seven Co closed flat for 0.7 cents.

Funds raised will be used for the rollout of the SimbleHome app next year and growth opportunities in Australia and the UK. The raise will also support repayments of liabilities and strengthen its balance sheet.

Tranche one of the raise will see 36.45 million shares issued at 2.3 cents, raising $838,000.

In tranche two, up to 7 million shares will be offered to raise the rest of the funds at the same issue price. Directors of Simble have agreed to subscribe for the total $162,000. However, tranche two is subject to shareholder approval at a general meeting next month.

For every two shares, one free attaching option will be available, with the exercise prices of five cents expiring 2 years from December 31.

Simble Solutions CEO Ronen Ghosh said he’s pleased with the strong investor support for the company’s strategy.

“We have seen momentum build over recent months and with our costs under control. The placement will provide critical working capital to propel the growth of the company,” he said.

Simble has also announced the appointment of Kim Clark as the company’s secretary. Ms Clark is an employee of BoardRoom and succeeds Hasaka Martin after his departure

Shares in Simble Solutions closed a staggering 35.71 per cent higher, worth 3.8 cents.

Originally, Comet intended to raise half a million dollars, however strong demand from shareholders saw over-subscriptions of $1.8 million. The company applied a scale back accepting an additional $500,000. Shares are being issued to eligible shareholders at 0.2 cents.

The SPP came in the wake of a $2 million placement last month. The money raised will be used for the company’s Santa Teresa Gold Project in Mexico and Barraba Copper Project in New South Wales.

Comet Managing Director Matthew O’Kane said he was pleased with the support from shareholders.

“It provides further validation for the company’s recent project acquisitions,” he said.

“We are now looking forward to commencing exploration works as soon as possible at both the Barraba Copper Project and the Santa Teresa Gold Project,” Matthew stated.

The Santa Teresa project includes two mineral claims, totalling 202 hectares in the El Alamo district of Mexico.

The Barraba Cooper project sits along the Peel Fault line in NSW and encompasses the historic Gulf Creek and Murchison copper mines. The region is historically known for copper, zinc, lead and precious metals.

Shares in Comet Resource closed 4.54 per cent higher for 2.3 cents.

Earlier this month the first tranche was completed with the issue of around 166 million shares for about $6 million. The placement was supported by existing institutional shareholders and a small number of new key Australian-based institutional investors.

The second tranche of the placement was completed today, allotting and issuing around 111.8 million shares to raise $4 million.

Funds from the placement will be used to enhance the company’s platform and build its customer base.

Co-founder and Chief Executive of 9Spokes Adrian Grant said the company is pleased with the completion of the placement.

“The Company is now funded for approximately two years based on current operations, enabling us to focus on continual enhancements of our platform, adding new app partners to our ecosystem, and most importantly, to focus on engaging new banking customers through our partnerships with Microsoft, Visa, and Fundation” he said.

Shares in 9Spokes closed 3.22 per cent higher on the market, trading for 3.2 cents.

Under the placement, around 225 million shares will be issued at 6.7 cents, representing a 9.9 per cent discount the five-day volume-weighted average price.

Boss directors will also participate in the placement to raise an additional $225,455, subject to shareholder approval, which will be discussed at the upcoming annual general meeting.

On September 25, the company announced it planned to evaluate the replacement of the existing solvent extraction columns to the NIMCIX IX system for its Honeymoon Uranium Project. The new system would increase Honeymoon’s production levels while reducing costs. Boss ordered an enhanced feasibility study which will incorporate these possible energy and cost savings.

Funds raised from the placement will be applied to these IX process optimisation studies, exploration activities and maintenance costs.

Boss Resources Managing Director and CEO Duncan Craib said the company is pleased with the strong demand from existing and new domestic and international investors for the placement.

“Proceeds from the placement secures the company’s first mover advantage as we progress our enhanced feasibility study and continue towards a Honeymoon re-start decision” he said

Shares in Boss Resources closed 6.94 per cent lower on the market, trading for 6.7 cents.